Q2 2024 United Therapeutics Corp Earnings Call Transcript
Good morning, everyone, and welcome to the United Therapeutics Corporation second-quarter 2024 earnings webcast. My name is Cole, and I'll be your conference operator today. (Operator Instructions) And please note that this call is being recorded. I would now like to turn the webcast over to Dewey Steadman, Head of Investor Relations, at United Therapeutics. Please go ahead.
Yes. Thank you, Cole. Good morning. It's my pleasure to welcome you to the United Therapeutics Corporation second-quarter 2024 earnings webcast.
Remarks we make today will include forward-looking statements representing our expectations or beliefs regarding future events. These statements involve risks and uncertainties that may cause actual results to differ materially. Our latest SEC filings, including Forms 10-K and 10-Q, contain additional information on these risks and uncertainties, and we assume no obligation to update these forward-looking statements. Remarks today may discuss the progress and results of clinical trials
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |